These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 3071598

  • 1. Cardiovascular and hormonal responses to DDAVP before and after beta-blockade in patients with mild essential hypertension.
    Fallo F, Patrassi G, Girolami A, Castellano M, Beschi M, Mantero F.
    J Hypertens Suppl; 1988 Dec; 6(4):S675-7. PubMed ID: 3071598
    [Abstract] [Full Text] [Related]

  • 2. Effects of DDAVP on renal hemodynamics and renin secretion in subjects with essential hypertension.
    Brink HS, Derkx FH, Boomsma F, Schalekamp MA.
    Clin Nephrol; 1994 Aug; 42(2):95-101. PubMed ID: 7955585
    [Abstract] [Full Text] [Related]

  • 3. 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.
    Brink HS, Derkx FH, Boomsma F, Brommer EJ, Schalekamp MA.
    Neth J Med; 1993 Aug; 43(1-2):5-12. PubMed ID: 8232694
    [Abstract] [Full Text] [Related]

  • 4. Effect of 1-desamino-8-D-arginine vasopressin (DDAVP) on vasopressin release and blood pressure during hemorrhage.
    Shimizu K, Nakao A.
    Endocrinol Jpn; 1992 Oct; 39(5):517-23. PubMed ID: 1478192
    [Abstract] [Full Text] [Related]

  • 5. Cardiovascular and renin responses to desmopressin in humans: role of prostacyclin and beta-adrenergic systems.
    Hasunuma K, Yamada K, Tamura Y, Yoshida S.
    Am J Physiol; 1991 Apr; 260(4 Pt 2):H1031-6. PubMed ID: 1849368
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of nadolol in treatment of hypertension.
    Volicer L, Liang CS, Gavras H, Tifft CP, Kershaw GR, Gavras I, Griffith DL, Vukovitch R, Brunner HR.
    J Clin Pharmacol; 1979 Apr; 19(2-3):137-47. PubMed ID: 33998
    [Abstract] [Full Text] [Related]

  • 15. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH, Davies RA, Fourney A.
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [Abstract] [Full Text] [Related]

  • 16. Effects of the calcium antagonist felodipine on the sympathetic and renin-angiotensin-aldosterone systems in essential hypertension.
    Katzman PL, Hulthén UL, Hökfelt B.
    Acta Med Scand; 1988 Nov; 223(2):125-31. PubMed ID: 3279724
    [Abstract] [Full Text] [Related]

  • 17. Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system.
    Bardoux P, Bichet DG, Martin H, Gallois Y, Marre M, Arthus MF, Lonergan M, Ruel N, Bouby N, Bankir L.
    Nephrol Dial Transplant; 2003 Mar; 18(3):497-506. PubMed ID: 12584270
    [Abstract] [Full Text] [Related]

  • 18. Repeated infusions of DDAVP induce low response of FVIII and vWF but not of plasminogen activators.
    Vicente V, Estellés A, Laso J, Moraleda JM, Rivera J, Aznar J.
    Thromb Res; 1993 Apr 15; 70(2):117-22. PubMed ID: 8322282
    [Abstract] [Full Text] [Related]

  • 19. Effect of DDAVP on plasma renin activity in man.
    Radó JP, Boer P.
    Int J Clin Pharmacol Biopharm; 1979 Jul 15; 17(7):307-10. PubMed ID: 489197
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.